Skip to main content

LIKMEZ

NDC 71656-066 · Saptalis Pharmaceuticals, LLC

Generic nameMetronidazole Oral
Dosage formSUSPENSION
RouteORAL
Active ingredient(s)METRONIDAZOLE
Strength100 mg/mL
Pharmacologic classNitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]
Marketing categoryNDA

Packages

71656-066-20 — 200 mL in 1 BOTTLE (71656-066-20)

71656-066-75 — 75 mL in 1 BOTTLE (71656-066-75)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

71335-0358 — Metronidazole, 71335-0858 — Metronidazole, 71335-1681 — Metronidazole, 71335-1703 — metronidazole, 71335-1775 — metronidazole, 71335-1838 — Metronidazole, 71335-1922 — Metronidazole, 71335-2640 — Metronidazole, 71335-2681 — metronidazole, 71335-2949 — metronidazole, 71656-067 — metronidazole, 72162-2259 — Metronidazole, 72162-2403 — Metronidazole, 72162-2468 — metronidazole, 72162-2677 — Metronidazole, 72162-2678 — Metronidazole, 72572-540 — Metronidazole, 72578-007 — metronidazole, 72578-008 — metronidazole, 72578-129 — Metronidazole, +161 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels